Composition:

Each (1)g cream contains (0.1)mg Fluocinolone acetonide, and (20)mg Lidocaine Hydrochloride.

Mechanism of Action:

This product contains fluocinolone acetonide, a topical corticosteroid with very strong anti-inflammatory,

anti-itching and vasoconstrictive energy, and Lidocaine, a local anesthetic.

Indications:

The cream is recommended to treatment Symptomatic of inflammation and itching in skin diseases that respond to topical corticosteroids,

such as external and internal hemorrhoids, perianal eczema, pruritus ani.

Contraindications:

Presence of hypersensitivity to the active substances or any of the excipients, severe renal disease, psychosis,

tuberculosis and syphilis diseases as well as bacterial diseases, mycotic or viral in the application zone.

Warnings and precautions:

In case of infection it is recommended to administer the appropriate one antimicrobial or antifungal agent, but if the infection is

not controlled then it is recommended discontinue the drug until the infection is completely controlled.

It is not recommended to be made use of topical corticosteroids for more than two weeks without re-examination of the patient by the specialist doctor.

Also, application of local anesthetic beyond 2 weeks does not recommended due to the risk of skin hypersensitivity. The possibility of malignancy should be ruled out before using the product.

In case irritation or bleeding from the rectum, treatment should be discontinued.

There is a possibility systemic absorption of the drug by the rectum.

Side Effects:

After long-term local use: skin irritation, burning sensation, hypersensitivity reactions, and secondary infections.

General after long-term local aging: Suppression of adrenal cortex function, decreased cortisol level in plasma

Dosage and administration:

Apply the cream 2-3 times a day and massage in gently. The cream can be applied and inside the rectum with the help of the special muzzle.

The duration of treatment ranges from 1 to 2 weeks.

Using during pregnancy or lactation:

Topical corticosteroids may be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus.

In such cases must not be administered in large quantities or for long periods especially in the first three months of pregnancy.

When the use of topical corticosteroids is necessary during breastfeeding, the amount of drug and length of treatment should be limited minimum.

Interactions with other drugs

Should tell doctor if you are taking antiarrhythmic drugs.